Header Logo

Connection

Parameswaran Venugopal to Lymphoma, B-Cell, Marginal Zone

Back to Details
This is a "connection" page, showing publications Parameswaran Venugopal has written about Lymphoma, B-Cell, Marginal Zone.
Parameswaran Venugopal
Connection Strength
0.098
Lymphoma, B-Cell, Marginal Zone
  1. Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma. Clin Lymphoma Myeloma Leuk. 2011 Dec; 11(6):467-74.
    View in: PubMed
    Score: 0.098
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.